Re: Thrown in the towel?
|
3
|
Resverlogix Corp.
|
Aug 03, 2022 10:44PM
|
Re: IR response
|
3
|
Resverlogix Corp.
|
May 07, 2022 07:51PM
|
Re: Question to ask at the AGM
|
3
|
Resverlogix Corp.
|
Oct 30, 2019 07:49PM
|
Re: Is there an obligation....
|
3
|
Resverlogix Corp.
|
Oct 29, 2019 09:24AM
|
Re: Up Up Up
|
3
|
Resverlogix Corp.
|
Sep 19, 2020 10:32AM
|
Re: 2023 Outlook per MD&A
|
3
|
Resverlogix Corp.
|
Apr 07, 2023 11:46AM
|
Re: Up Up Up
|
3
|
Resverlogix Corp.
|
Sep 19, 2020 10:35AM
|
Re: Comments on the AGM
|
3
|
Resverlogix Corp.
|
Nov 10, 2019 04:40PM
|
Re: RVX.WT & RVX.WT.A
|
3
|
Resverlogix Corp.
|
Dec 03, 2020 09:48AM
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:06PM
|
Re: A couple of things
|
3
|
Resverlogix Corp.
|
May 05, 2022 01:00AM
|
Re: AGM June 21
|
3
|
Resverlogix Corp.
|
May 13, 2022 09:35PM
|
Post-COVID Conditions | CDC
|
3
|
Resverlogix Corp.
|
Oct 24, 2021 10:15AM
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Mar 29, 2020 02:43PM
|
Re: Moderna news
|
3
|
Resverlogix Corp.
|
Aug 13, 2020 06:22PM
|
Management
|
3
|
Resverlogix Corp.
|
Apr 04, 2021 09:26PM
|
Re: RVX is
|
3
|
Resverlogix Corp.
|
Apr 04, 2020 11:26AM
|
Re: a new study that one researcher called "stunning."
|
3
|
Resverlogix Corp.
|
Feb 11, 2022 09:30AM
|
What am I missing
|
3
|
Resverlogix Corp.
|
Nov 26, 2021 09:00AM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 18, 2022 08:12PM
|